Management of Patients with Cardiac Glycoside Toxicity

Activity Overview

This course provides physicians, advanced care practitioners, students, and nurses with an approach to managing a patient with cardiac glycoside toxicity. Upon completion of this course, learners will be able to effectively assess, diagnose, and treat patients presenting with cardiac glycoside toxicity in accordance with established guidelines and best practices covered in the course material.

This course is divided into the following lessons to help you properly manage patients with cardiac glycoside toxicity in the Emergency Department. Please consider the estimated time required noted below, and plan accordingly to complete each lesson:

• Lesson 1: Introduction
• Lesson 2: Assessment
• Lesson 3: Diagnosis
• Lesson 4: Treatment
• Lesson 5: Practice

Please see the Course Syllabus tab here for additional detail.

Target Audience

This activity is designed for an audience of physicians, advanced care practitioners, students, and nurses.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

• Assess, diagnose, and treat patients presenting with cardiac glycoside toxicity in accordance with established guidelines and best practices covered in the course material

View Syllabus

Continuing Education

Enduring Continuing Education credits for Physicians, Physician Associates, Nurse Practitioners, Nurses, and Pharmacists is provided by AKH Inc., Advancing Knowledge in Healthcare. It is expected that learners will receive 1.5 credits after completing this activity.

For more information, click here. 

Commercial Support

This activity is supported by an independent medical education grant from BTG International Inc., a SERB Pharmaceuticals company.

For detailed information about disclosures and the CE disclaimer, please review the Learner Notification, located here.

Questions?

Please write to ACMT at events@acmt.net.

Course Syllabus

Lesson 1: Introduction
(Estimated time required: 2 minutes)
Lesson 1 overviews the course and provides a menu of lessons from which to choose.

Lesson 2: Assessment
(Estimated time required: 20 minutes)
Lesson 2 reviews the standard assessment process, highlighting critical points for proper assessment in cases of cardiac glycoside toxicity.

Lesson 3: Diagnosis
(Estimated time required: 25 minutes)
Lesson 3 focuses on the diagnostic measures required to properly diagnose cardiac glycoside toxicity.

Lesson 4: Treatment
(Estimated time required: 15 minutes)
Lesson 4 presents the guidelines for selecting treatment and calculating dose, depending on case scenario.

Lesson 5: Practice 
(Estimated time required: 20 minutes)
Lesson 5 allows the learner to practice applying all of the decision-making guidelines (learned in previous lessons) to two cases.

Registration Rates

Registration includes:

• Access to course content
• 1.5 Continuing Education Certificate. Available credits: Continuing Medical Education (CME), Continuing Nursing Education (CNE), and Continuing Pharmacy Education (CPE).

Member Rates

Non-Member Rates

ACMT Membership

Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership

Refunds and Cancellations

For information on ACMT's Cancellation and refund policy, click here.

Questions?

For any questions, please email us at events@acmt.net.

Continuing Education

Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare. 

Criteria for Success

To obtain a certificate of completion, a score of 80% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit.

URL: https://education.acmt.net/p/CardiacGlycosides

If you have questions about this CE activity, please contact AKH Inc at JGoldman@akhcme.com.

Credit for this activity will expire on October 1, 2025. Please complete the course and claim credit before this date.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians 

AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Credit being awarded: 1.5 ANCC contact hours.

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.5 contact hours.

Physician Associate

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 9/1/2025. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT).  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.5 contact hour(s) (which includes 1.0 hour(s) of pharmacology).

Commercial Support
This activity is supported by an independent medical education grant from BTG International Inc.

Disclosures
A full list of speaker disclosures is available on the Learner Notification, available for download below.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.